Skip to main content
logo
MedCap AB (publ) (STO:MCAP)
Sweden flag Sweden · Delayed Price · Currency is SEK
608.00
-15.00 (-2.41%)
Oct 31, 2025, 12:59 PM CET

Revenue by Geography

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212014 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 2014 - 2020
Sweden Revenue
914.30M898.40M
Log In
Log In
Log In
Upgrade
Nordic (ex-Sweden) Revenue
567.70M448.60M
Log In
Log In
Log In
Upgrade
Europe (ex-Nordic) Revenue
451.40M384.70M
Log In
Log In
Log In
Upgrade
Rest of the World Revenue
57.80M75.10M
Log In
Log In
Log In
Upgrade

Revenue Breakdown

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212014 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 2014 - 2020
Assistive Tech Revenue
915.60M767.20M
Log In
Log In
Log In
Upgrade
Medtech Revenue (Post-Q2 2023 Reporting)
652.60M607.70M
Log In
Log In
Log In
Upgrade
Medtech Revenue (Pre-Q3 2023 Reporting)
1.57B1.37B
Log In
Log In
Log In
Upgrade
Specialty Pharma Revenue
423.00M431.80M
Log In
Log In
Log In
Upgrade

Revenue Breakdown 2

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212014 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 2014 - 2020
Pharmaceuticals Revenue
413.20M420.50M
Log In
Log In
Log In
Upgrade
Assistive Technology Revenue
915.30M765.90M
Log In
Log In
Log In
Upgrade
Medical Devices Revenue
311.50M322.70M
Log In
Log In
Log In
Upgrade
Nutrition & Other Food Revenue
307.00M251.80M
Log In
Log In
Log In
Upgrade
Other Product Revenue
44.70M45.90M
Log In
Log In
Log In
Upgrade

Adjusted EBITDA

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212014 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 2014 - 2020
Assistive Tech Adjusted EBITDA
250.20M212.00M
Log In
Log In
Log In
Upgrade
Medtech Adjusted EBITDA (Post-Q2 2023 Reporting)
131.80M138.30M
Log In
Log In
Log In
Upgrade
Medtech Adjusted EBITDA (Pre-Q3 2023 Reporting)
382.00M350.30M
Log In
Log In
Log In
Upgrade
Specialty Pharma Adjusted EBITDA
44.50M59.20M
Log In
Log In
Log In
Upgrade
Other and Eliminations from Adjusted EBITDA
-24.10M-21.70M
Log In
Log In
Log In
Upgrade

EBIT

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212014 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 2014 - 2020
Assistive Tech Operating Profit
186.20M164.10M
Log In
Log In
Log In
Upgrade
Medtech Operating Profit (Post-Q2 2023 Reporting)
89.30M98.70M
Log In
Log In
Log In
Upgrade
Medtech Operating Profit (Pre-Q3 2023 Reporting)
275.50M262.80M
Log In
Log In
Log In
Upgrade
Specialty Pharma Operating Profit
21.20M33.40M
Log In
Log In
Log In
Upgrade
Other and Eliminations from Operating Profit
-26.20M-23.90M
Log In
Log In
Log In
Upgrade
Updated Sep 30, 2025. Data Source: Fiscal.ai.